<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;ff=20240305050936&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;fc=20230708114047&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;ff=20240305050936&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;fc=20230708114047&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Tue, 05 Mar 2024 10:09:37 +0000</lastbuilddate>
<pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Metabolic product of excess niacin is linked to increased risk of cardiovascular events</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38438588/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Mar 4. doi: 10.1038/s41569-024-01005-1. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38438588/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38438588</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01005-1>10.1038/s41569-024-01005-1</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38438588</guid>
<pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
<dc:creator>Gregory B Lim</dc:creator>
<dc:date>2024-03-04</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Metabolic product of excess niacin is linked to increased risk of cardiovascular events</dc:title>
<dc:identifier>pmid:38438588</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01005-1</dc:identifier>
</item>
<item>
<title>Shortening in-hospital stay after transcatheter aortic valve implantation: a déjà vu in percutaneous interventions</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38437639/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Mar 4:ehae096. doi: 10.1093/eurheartj/ehae096. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38437639/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38437639</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae096>10.1093/eurheartj/ehae096</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38437639</guid>
<pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
<dc:creator>Julinda Mehilli</dc:creator>
<dc:date>2024-03-04</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Shortening in-hospital stay after transcatheter aortic valve implantation: a déjà vu in percutaneous interventions</dc:title>
<dc:identifier>pmid:38437639</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae096</dc:identifier>
</item>
<item>
<title>Weekly journal scan: a new small-interfering RNA to fight a genetic cardiovascular risk factor</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38437638/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Mar 4:ehae118. doi: 10.1093/eurheartj/ehae118. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38437638/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38437638</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae118>10.1093/eurheartj/ehae118</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38437638</guid>
<pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
<dc:creator>Daniela Pedicino</dc:creator>
<dc:creator>Massimo Volpe</dc:creator>
<dc:date>2024-03-04</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Weekly journal scan: a new small-interfering RNA to fight a genetic cardiovascular risk factor</dc:title>
<dc:identifier>pmid:38437638</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae118</dc:identifier>
</item>
<item>
<title>Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38437633/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: The intervention was simple and fast to implement, and was effective and safe to reduce LOS and increase the proportion of patients discharged early after TAVI (NCT04503655).</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Mar 4:ehae081. doi: 10.1093/eurheartj/ehae081. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: The length of stay (LOS) after transcatheter aortic valve implantation (TAVI) remains extremely variable whereas early discharge has been shown to be feasible and safe. The study objective was to evaluate the efficacy and safety of an intervention aimed at reducing LOS after transfemoral TAVI.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: FAST-TAVI II is a prospective, multicentre, cluster, randomized, controlled study including patients with severe symptomatic aortic stenosis, who had transfemoral TAVI. The intervention consisted in a dedicated training programme to implement 10 quality of care measures to reduce LOS with an implementation phase of eight weeks. The primary endpoint was the proportion of patients discharged early within 3 days. Secondary endpoints included: LOS, 30-day mortality and 30-day incidence of readmission for cardiovascular events.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: During the study period, 969 patients were enrolled in the intervention group and 860 patients in the control group. Mean age was 81.9 ± 6.6 years and mean EuroSCORE II was 4.4 ± 4.5%. Early discharge was achieved in 563 (58.1%) patients in the intervention group vs. 364 (42.3%) patients in the control group (P &lt; .0001). Median LOS was significantly reduced in the intervention group compared to the control group [3 (IQR: 3) vs. 4 days (IQR: 3), P &lt; .0001]. Thirty-day mortality was low and similar in the two groups (0.5% vs. 0.9%, P = .30), as were 30-day readmissions (4.6% vs. 2.8%, P = .28).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: The intervention was simple and fast to implement, and was effective and safe to reduce LOS and increase the proportion of patients discharged early after TAVI (NCT04503655).</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38437633/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38437633</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae081>10.1093/eurheartj/ehae081</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38437633</guid>
<pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
<dc:creator>Eric Durand</dc:creator>
<dc:creator>Delphine Beziau-Gasnier</dc:creator>
<dc:creator>Morgane Michel</dc:creator>
<dc:creator>Bernard Iung</dc:creator>
<dc:creator>Didier Tchetche</dc:creator>
<dc:creator>Guillaume Bonnet</dc:creator>
<dc:creator>Thibault Lhermusier</dc:creator>
<dc:creator>Martine Gilard</dc:creator>
<dc:creator>Geraud Souteyrand</dc:creator>
<dc:creator>Claire Bouleti</dc:creator>
<dc:creator>Patrick Ohlmann</dc:creator>
<dc:creator>Thierry Lefevre</dc:creator>
<dc:creator>Farzin Beygui</dc:creator>
<dc:creator>Stephan Chassaing</dc:creator>
<dc:creator>Karine Chevreul</dc:creator>
<dc:creator>Hélène Eltchaninoff</dc:creator>
<dc:creator>FAST-TAVI II</dc:creator>
<dc:creator>STOP-AS investigators</dc:creator>
<dc:date>2024-03-04</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial</dc:title>
<dc:identifier>pmid:38437633</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae081</dc:identifier>
</item>
<item>
<title>Weekly journal scan: do biodegradable polymer stents provide a durable benefit in patients with ST-segment elevation myocardial infarction?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38437630/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Mar 4:ehae119. doi: 10.1093/eurheartj/ehae119. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38437630/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38437630</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae119>10.1093/eurheartj/ehae119</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38437630</guid>
<pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
<dc:creator>Rocco Vergallo</dc:creator>
<dc:creator>Leonarda Galiuto</dc:creator>
<dc:date>2024-03-04</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Weekly journal scan: do biodegradable polymer stents provide a durable benefit in patients with ST-segment elevation myocardial infarction?</dc:title>
<dc:identifier>pmid:38437630</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae119</dc:identifier>
</item>
<item>
<title>Thrombosis of a mechanical aortic valve: stuck between a clot and a hard place</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38437581/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Mar 4:ehae115. doi: 10.1093/eurheartj/ehae115. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38437581/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38437581</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae115>10.1093/eurheartj/ehae115</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38437581</guid>
<pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
<dc:creator>Michael McGregor</dc:creator>
<dc:creator>Hilary Bews</dc:creator>
<dc:creator>Davinder S Jassal</dc:creator>
<dc:date>2024-03-04</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Thrombosis of a mechanical aortic valve: stuck between a clot and a hard place</dc:title>
<dc:identifier>pmid:38437581</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae115</dc:identifier>
</item>
<item>
<title>The Shape of Things to Come? Is a Trial of Combined Interventional Procedures Necessary in Today's World?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38437486/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Mar 5;149(10):744-746. doi: 10.1161/CIRCULATIONAHA.123.067744. Epub 2024 Mar 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38437486/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38437486</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067744>10.1161/CIRCULATIONAHA.123.067744</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38437486</guid>
<pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
<dc:creator>Neal S Kleiman</dc:creator>
<dc:creator>Sachin S Goel</dc:creator>
<dc:date>2024-03-04</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>The Shape of Things to Come? Is a Trial of Combined Interventional Procedures Necessary in Today's World?</dc:title>
<dc:identifier>pmid:38437486</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067744</dc:identifier>
</item>
<item>
<title>The Next Chapter of Renal Denervation After US Food and Drug Administration Approval</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38437485/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Mar 5;149(10):760-763. doi: 10.1161/CIRCULATIONAHA.123.067983. Epub 2024 Mar 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38437485/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38437485</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067983>10.1161/CIRCULATIONAHA.123.067983</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38437485</guid>
<pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
<dc:creator>Wanpen Vongpatanasin</dc:creator>
<dc:creator>Tayo Addo</dc:creator>
<dc:date>2024-03-04</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>The Next Chapter of Renal Denervation After US Food and Drug Administration Approval</dc:title>
<dc:identifier>pmid:38437485</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067983</dc:identifier>
</item>
<item>
<title>Sudden Cardiac Arrest During Sports in Children and Adolescents</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38437484/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Mar 5;149(10):794-796. doi: 10.1161/CIRCULATIONAHA.123.064739. Epub 2024 Mar 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38437484/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38437484</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064739>10.1161/CIRCULATIONAHA.123.064739</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38437484</guid>
<pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
<dc:creator>Philipp Bohm</dc:creator>
<dc:creator>Sergio Barra</dc:creator>
<dc:creator>Orianne Weizman</dc:creator>
<dc:creator>Kumar Narayanan</dc:creator>
<dc:creator>Tim Meyer</dc:creator>
<dc:creator>Christian Schmied</dc:creator>
<dc:creator>Wulfran Bougouin</dc:creator>
<dc:creator>Xavier Jouven</dc:creator>
<dc:creator>Eloi Marijon</dc:creator>
<dc:date>2024-03-04</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Sudden Cardiac Arrest During Sports in Children and Adolescents</dc:title>
<dc:identifier>pmid:38437484</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.064739</dc:identifier>
</item>
<item>
<title>The Future of Pharmacoinvasive Therapy for ST-Segment-Elevation Myocardial Infarction Reperfusion in the Post-STREAM Era</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38437483/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Mar 5;149(10):732-733. doi: 10.1161/CIRCULATIONAHA.123.066703. Epub 2024 Mar 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38437483/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38437483</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.066703>10.1161/CIRCULATIONAHA.123.066703</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38437483</guid>
<pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
<dc:creator>Thomas Alexander</dc:creator>
<dc:creator>Dharam J Kumbhani</dc:creator>
<dc:creator>Ajit Mullasari Sankardas</dc:creator>
<dc:date>2024-03-04</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>The Future of Pharmacoinvasive Therapy for ST-Segment-Elevation Myocardial Infarction Reperfusion in the Post-STREAM Era</dc:title>
<dc:identifier>pmid:38437483</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.066703</dc:identifier>
</item>
<item>
<title>Temporal Effects of Safflower Oil Diet-Based Linoleic Acid Supplementation on Barth Syndrome Cardiomyopathy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38437482/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Mar 5;149(10):790-793. doi: 10.1161/CIRCULATIONAHA.123.065414. Epub 2024 Mar 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38437482/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38437482</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065414>10.1161/CIRCULATIONAHA.123.065414</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38437482</guid>
<pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
<dc:creator>Siting Zhu</dc:creator>
<dc:creator>Jing Pang</dc:creator>
<dc:creator>Anh Nguyen</dc:creator>
<dc:creator>Changming Tan</dc:creator>
<dc:creator>Alexandria Tso</dc:creator>
<dc:creator>Tiana Huynh</dc:creator>
<dc:creator>Yusu Gu</dc:creator>
<dc:creator>Asa B Gustafsson</dc:creator>
<dc:creator>Frédéric M Vaz</dc:creator>
<dc:creator>Sylvia M Evans</dc:creator>
<dc:creator>Xi Fang</dc:creator>
<dc:date>2024-03-04</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Temporal Effects of Safflower Oil Diet-Based Linoleic Acid Supplementation on Barth Syndrome Cardiomyopathy</dc:title>
<dc:identifier>pmid:38437482</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065414</dc:identifier>
</item>
<item>
<title>Cardiovascular and Planetary Health: Two Sides of the Same Planet</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38437481/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Mar 5;149(10):729-731. doi: 10.1161/CIRCULATIONAHA.123.065486. Epub 2024 Mar 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38437481/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38437481</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065486>10.1161/CIRCULATIONAHA.123.065486</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38437481</guid>
<pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
<dc:creator>Sanjay Rajagopalan</dc:creator>
<dc:creator>Robert D Brook</dc:creator>
<dc:date>2024-03-04</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Cardiovascular and Planetary Health: Two Sides of the Same Planet</dc:title>
<dc:identifier>pmid:38437481</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065486</dc:identifier>
</item>
<item>
<title>Letter by Khan et al Regarding Article, "Long-Term Incidence of Ischemic Stroke After Transient Ischemic Attack: A Nationwide Study from 2014 to 2020"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38437480/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Mar 5;149(10):797-798. doi: 10.1161/CIRCULATIONAHA.123.067840. Epub 2024 Mar 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38437480/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38437480</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067840>10.1161/CIRCULATIONAHA.123.067840</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38437480</guid>
<pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
<dc:creator>Faizan Khan</dc:creator>
<dc:creator>Shelagh B Coutts</dc:creator>
<dc:creator>Michael D Hill</dc:creator>
<dc:date>2024-03-04</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Khan et al Regarding Article, "Long-Term Incidence of Ischemic Stroke After Transient Ischemic Attack: A Nationwide Study from 2014 to 2020"</dc:title>
<dc:identifier>pmid:38437480</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067840</dc:identifier>
</item>
<item>
<title>Correction to: 2023 Scientific Sessions Abstract 16304</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38437479/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Mar 5;149(10):e955. doi: 10.1161/CIR.0000000000001224. Epub 2024 Mar 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38437479/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38437479</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001224>10.1161/CIR.0000000000001224</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38437479</guid>
<pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
<dc:date>2024-03-04</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: 2023 Scientific Sessions Abstract 16304</dc:title>
<dc:identifier>pmid:38437479</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001224</dc:identifier>
</item>
<item>
<title>Correction to: 2023 Scientific Sessions Abstract 12093</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38437478/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Mar 5;149(10):e953. doi: 10.1161/CIR.0000000000001222. Epub 2024 Mar 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38437478/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38437478</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001222>10.1161/CIR.0000000000001222</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38437478</guid>
<pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
<dc:date>2024-03-04</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: 2023 Scientific Sessions Abstract 12093</dc:title>
<dc:identifier>pmid:38437478</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001222</dc:identifier>
</item>
<item>
<title>Correction to: 2023 Scientific Sessions Abstract 14413</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38437477/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Mar 5;149(10):e954. doi: 10.1161/CIR.0000000000001223. Epub 2024 Mar 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38437477/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38437477</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001223>10.1161/CIR.0000000000001223</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38437477</guid>
<pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
<dc:date>2024-03-04</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: 2023 Scientific Sessions Abstract 14413</dc:title>
<dc:identifier>pmid:38437477</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001223</dc:identifier>
</item>
<item>
<title>Response by Vinding and Fosbøl to Letter Regarding Article, "Long-Term Incidence of Ischemic Stroke After Transient Ischemic Attack: A Nationwide Study from 2014 to 2020"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38437475/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Mar 5;149(10):799. doi: 10.1161/CIRCULATIONAHA.123.068241. Epub 2024 Mar 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38437475/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38437475</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.068241>10.1161/CIRCULATIONAHA.123.068241</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38437475</guid>
<pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
<dc:creator>Naja Emborg Vinding</dc:creator>
<dc:creator>Emil Loldrup Fosbøl</dc:creator>
<dc:date>2024-03-04</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Response by Vinding and Fosbøl to Letter Regarding Article, "Long-Term Incidence of Ischemic Stroke After Transient Ischemic Attack: A Nationwide Study from 2014 to 2020"</dc:title>
<dc:identifier>pmid:38437475</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.068241</dc:identifier>
</item>
<item>
<title>Toward Heart-Healthy and Sustainable Cities: A Policy Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38436070/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>Nearly 56% of the global population lives in cities, with this number expected to increase to 6.6 billion or >;70% of the world's population by 2050. Given that cardiometabolic diseases are the leading causes of morbidity and mortality in people living in urban areas, transforming cities and urban provisioning systems (or urban systems) toward health, equity, and economic productivity can enable the dual attainment of climate and health goals. Seven urban provisioning systems that provide food,...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Mar 4. doi: 10.1161/CIR.0000000000001217. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Nearly 56% of the global population lives in cities, with this number expected to increase to 6.6 billion or >;70% of the world's population by 2050. Given that cardiometabolic diseases are the leading causes of morbidity and mortality in people living in urban areas, transforming cities and urban provisioning systems (or urban systems) toward health, equity, and economic productivity can enable the dual attainment of climate and health goals. Seven urban provisioning systems that provide food, energy, mobility-connectivity, housing, green infrastructure, water management, and waste management lie at the core of human health, well-being, and sustainability. These provisioning systems transcend city boundaries (eg, demand for food, water, or energy is met by transboundary supply); thus, transforming the entire system is a larger construct than local urban environments. Poorly designed urban provisioning systems are starkly evident worldwide, resulting in unprecedented exposures to adverse cardiometabolic risk factors, including limited physical activity, lack of access to heart-healthy diets, and reduced access to greenery and beneficial social interactions. Transforming urban systems with a cardiometabolic health-first approach could be accomplished through integrated spatial planning, along with addressing current gaps in key urban provisioning systems. Such an approach will help mitigate undesirable environmental exposures and improve cardiovascular and metabolic health while improving planetary health. The purposes of this American Heart Association policy statement are to present a conceptual framework, summarize the evidence base, and outline policy principles for transforming key urban provisioning systems to heart-health and sustainability outcomes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38436070/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38436070</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001217>10.1161/CIR.0000000000001217</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38436070</guid>
<pubDate>Mon, 04 Mar 2024 06:00:00 -0500</pubDate>
<dc:creator>Sanjay Rajagopalan</dc:creator>
<dc:creator>Anu Ramaswami</dc:creator>
<dc:creator>Aruni Bhatnagar</dc:creator>
<dc:creator>Robert D Brook</dc:creator>
<dc:creator>Mark Fenton</dc:creator>
<dc:creator>Christopher Gardner</dc:creator>
<dc:creator>Roni Neff</dc:creator>
<dc:creator>Armistead G Russell</dc:creator>
<dc:creator>Karen C Seto</dc:creator>
<dc:creator>Laurie P Whitsel</dc:creator>
<dc:creator>American Heart Association Council on Hypertension; Council on Lifestyle and Cardiometabolic Health; Council on Peripheral Vascular Disease; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Cardiovascular Surgery and Anesthesia; and the American Heart Association Advocacy Coordinating Committee</dc:creator>
<dc:date>2024-03-04</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Toward Heart-Healthy and Sustainable Cities: A Policy Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:38436070</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001217</dc:identifier>
</item>
<item>
<title>Early hybrid cardiac rehabilitation in congenital heart disease: the QUALIREHAB trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38430485/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: This early hybrid cardiac rehabilitation programme improved HRQoL, body mass index, physical activity, and disease knowledge, in youth with CHD, opening up the possibility for the QUALIREHAB programme to be rolled out to the adult population of CHD and non-congenital cardiac disease.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Mar 2:ehae085. doi: 10.1093/eurheartj/ehae085. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Cardiopulmonary fitness in congenital heart disease (CHD) decreases faster than in the general population resulting in impaired health-related quality of life (HRQoL). As the standard of care seems insufficient to encourage and maintain fitness, an early hybrid cardiac rehabilitation programme could improve HRQoL in CHD.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The QUALIREHAB multicentre, randomized, controlled trial evaluated and implemented a 12-week centre- and home-based hybrid cardiac rehabilitation programme, including multidisciplinary care and physical activity sessions. Adolescent and young adult CHD patients with impaired cardiopulmonary fitness were randomly assigned to either the intervention (i.e. cardiac rehabilitation) or the standard of care. The primary outcome was the change in HRQoL from baseline to 12-month follow-up in an intention-to-treat analysis. The secondary outcomes were the change in cardiovascular parameters, cardiopulmonary fitness, and mental health.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The expected number of 142 patients was enroled in the study (mean age 17.4 ± 3.4 years, 52% female). Patients assigned to the intervention had a significant positive change in HRQoL total score [mean difference 3.8; 95% confidence interval (CI) 0.2; 7.3; P = .038; effect size 0.34], body mass index [mean difference -0.7 kg/m2 (95% CI -1.3; -0.1); P = .022; effect size 0.41], level of physical activity [mean difference 2.5 (95% CI 0.1; 5); P = .044; effect size 0.39], and disease knowledge [mean difference 2.7 (95% CI 0.8; 4.6); P = .007; effect size 0.51]. The per-protocol analysis confirmed these results with a higher magnitude of differences. Acceptability, safety, and short-time effect of the intervention were good to excellent.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: This early hybrid cardiac rehabilitation programme improved HRQoL, body mass index, physical activity, and disease knowledge, in youth with CHD, opening up the possibility for the QUALIREHAB programme to be rolled out to the adult population of CHD and non-congenital cardiac disease.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38430485/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38430485</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae085>10.1093/eurheartj/ehae085</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38430485</guid>
<pubDate>Sat, 02 Mar 2024 06:00:00 -0500</pubDate>
<dc:creator>Pascal Amedro</dc:creator>
<dc:creator>Arthur Gavotto</dc:creator>
<dc:creator>Helena Huguet</dc:creator>
<dc:creator>Luc Souilla</dc:creator>
<dc:creator>Anne-Cecile Huby</dc:creator>
<dc:creator>Stefan Matecki</dc:creator>
<dc:creator>Anne Cadene</dc:creator>
<dc:creator>Gregoire De La Villeon</dc:creator>
<dc:creator>Marie Vincenti</dc:creator>
<dc:creator>Oscar Werner</dc:creator>
<dc:creator>Charlene Bredy</dc:creator>
<dc:creator>Kathleen Lavastre</dc:creator>
<dc:creator>Hamouda Abassi</dc:creator>
<dc:creator>Sarah Cohen</dc:creator>
<dc:creator>Sebastien Hascoet</dc:creator>
<dc:creator>Claire Dauphin</dc:creator>
<dc:creator>Aurelie Chalard</dc:creator>
<dc:creator>Yves Dulac</dc:creator>
<dc:creator>Nathalie Souletie</dc:creator>
<dc:creator>Helene Bouvaist</dc:creator>
<dc:creator>Stephanie Douchin</dc:creator>
<dc:creator>Matthias Lachaud</dc:creator>
<dc:creator>Caroline Ovaert</dc:creator>
<dc:creator>Camille Soulatges</dc:creator>
<dc:creator>Nicolas Combes</dc:creator>
<dc:creator>Jean-Benoit Thambo</dc:creator>
<dc:creator>Xavier Iriart</dc:creator>
<dc:creator>Fanny Bajolle</dc:creator>
<dc:creator>Damien Bonnet</dc:creator>
<dc:creator>Helene Ansquer</dc:creator>
<dc:creator>Jean-Guillaume Delpey</dc:creator>
<dc:creator>Laurence Cohen</dc:creator>
<dc:creator>Marie-Christine Picot</dc:creator>
<dc:creator>Sophie Guillaumont</dc:creator>
<dc:creator>QUALIREHAB Study Group</dc:creator>
<dc:date>2024-03-02</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Early hybrid cardiac rehabilitation in congenital heart disease: the QUALIREHAB trial</dc:title>
<dc:identifier>pmid:38430485</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae085</dc:identifier>
</item>
<item>
<title>Correction to: Conventional heart failure therapy in cardiac ATTR amyloidosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38428942/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Mar 1:ehae140. doi: 10.1093/eurheartj/ehae140. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38428942/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38428942</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae140>10.1093/eurheartj/ehae140</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38428942</guid>
<pubDate>Fri, 01 Mar 2024 06:00:00 -0500</pubDate>
<dc:date>2024-03-01</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Correction to: Conventional heart failure therapy in cardiac ATTR amyloidosis</dc:title>
<dc:identifier>pmid:38428942</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae140</dc:identifier>
</item>
<item>
<title>Underdetected dispersal and extensive local transmission drove the 2022 mpox epidemic</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38428425/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240305050936&amp;v=2.18.0.post9+e462414
      <description>The World Health Organization declared mpox a public health emergency of international concern in July 2022. To investigate global mpox transmission and population-level changes associated with controlling spread, we built phylogeographic and phylodynamic models to analyze MPXV genomes from five global regions together with air traffic and epidemiological data. Our models reveal community transmission prior to detection, changes in case reporting throughout the epidemic, and a large degree of...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Feb 23:S0092-8674(24)00124-7. doi: 10.1016/j.cell.2024.02.003. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The World Health Organization declared mpox a public health emergency of international concern in July 2022. To investigate global mpox transmission and population-level changes associated with controlling spread, we built phylogeographic and phylodynamic models to analyze MPXV genomes from five global regions together with air traffic and epidemiological data. Our models reveal community transmission prior to detection, changes in case reporting throughout the epidemic, and a large degree of transmission heterogeneity. We find that viral introductions played a limited role in prolonging spread after initial dissemination, suggesting that travel bans would have had only a minor impact. We find that mpox transmission in North America began declining before more than 10% of high-risk individuals in the USA had vaccine-induced immunity. Our findings highlight the importance of broader routine specimen screening surveillance for emerging infectious diseases and of joint integration of genomic and epidemiological information for early outbreak control.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38428425/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240305050936&v=2.18.0.post9+e462414">38428425</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.02.003>10.1016/j.cell.2024.02.003</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38428425</guid>
<pubDate>Fri, 01 Mar 2024 06:00:00 -0500</pubDate>
<dc:creator>Miguel I Paredes</dc:creator>
<dc:creator>Nashwa Ahmed</dc:creator>
<dc:creator>Marlin Figgins</dc:creator>
<dc:creator>Vittoria Colizza</dc:creator>
<dc:creator>Philippe Lemey</dc:creator>
<dc:creator>John T McCrone</dc:creator>
<dc:creator>Nicola Müller</dc:creator>
<dc:creator>Cécile Tran-Kiem</dc:creator>
<dc:creator>Trevor Bedford</dc:creator>
<dc:date>2024-03-01</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Underdetected dispersal and extensive local transmission drove the 2022 mpox epidemic</dc:title>
<dc:identifier>pmid:38428425</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.02.003</dc:identifier>
</item>





























</channel>
</rss>